Alfredo Iacoangeli

Jan 14, 2025 | nature.com | Lachlan Gilchrist |Thomas P. Spargo |Rebecca Green |David Howard |Jackson G. Thorp |Brett N. Adey | +25 more

AbstractDepression is a risk factor for the later development of Alzheimer’s disease (AD), but evidence for the genetic relationship is mixed. Assessing depression symptom-specific genetic associations may better clarify this relationship.

Aug 13, 2024 | kcl.ac.uk | Alfredo Iacoangeli

Dr Alfredo Iacoangeli has been awarded £983,708 funding from the Medical Research Council (MRC) to explore how genetic sequences acquired millions of years ago from ancient viral infections might influence the risk and progression of Amyotrophic Lateral Sclerosis (ALS). Around eight per cent of human DNA is made up of genetic sequences acquired from ancient viral infections which date back up to millions of years. These sequences are known as human endogenous retroviruses (HERVs).

Jul 3, 2024 | kcl.ac.uk | Alfredo Iacoangeli

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards totalling £1.47 million to fund research into Motor Neuron Disease (MND). The projects are part of a £5.8 million investment by the Medical Research Council and the National Institute for Health and Care Research (NIHR) to speed up the development of treatments for MND, and the related condition of Frontotemporal dementia (FTD).

Jul 2, 2024 | nature.com | Alfredo Iacoangeli |Simon D. Topp |Puja R Mehta |Naomi Limbachiya |Kelly Williams |Wade K. Self | +15 more

Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34620-y, published online 12 November 2022The original version of this Article contained an error in Figure 4. Under the heading ‘Disease duration (months)’, all disease durations were reported as ‘disease duration’ rather than reporting the numerical value. The correct version now reports the disease duration in months instead of the original, incorrect ‘disease duration’.

Jun 18, 2024 | kcl.ac.uk | Alfredo Iacoangeli

The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia. On 13 June 2024, King’s MND Care and Research Centre proudly welcomed a distinguished delegation from the Perron Institute and the Western Australian Government. This visit marked a significant milestone in the ongoing collaboration between King’s College London, King's College Hospital, and the Perron Institute.